Finasteride Tablet, Film Coated
Product Images NDC 70518-3600

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 70518-3600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Finasteride 5mg 70518 3600 00)

Label for Finasteride 5 mg film-coated tablet, quantity 1 tablet, repackaged by RemedyRepack Inc. It indicates prescription use only (RX ONLY) and includes warnings against use or handling by women or children. Manufactured by Ascend Labs, LLC in Montvale, NJ. Storage instructions are also provided.*

FDA Label Image

Finasteride Figure 1 (Finasteride Fig.1)

A line graph showing mean change from baseline plus or minus one standard error over a four-year period. It compares two groups: one treated with Finasteride and the other with a placebo. The graph shows the number of subjects in each group at baseline and at each yearly interval up to year four, illustrating a greater downward trend in the Finasteride group compared to placebo.*

FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2)

A line graph displaying the percent of patients over 48 months of observation time comparing Finasteride and placebo groups. The Finasteride group shows a consistently lower percent of patients compared to the placebo group. The graph includes cumulative event counts and number at risk per year for both groups in a table below the chart.*

FDA Label Image

Finasteride Figure 2 (Finasteride Fig.3)

A line graph depicting the mean percent change from baseline over four years for two groups: Placebo and Finasteride. The y-axis shows percent change from baseline, ranging from -20 to 20. The x-axis shows time points: Baseline, Year 1, Year 2, Year 3, and Year 4. The Placebo group (circles) shows an increasing trend, while the Finasteride group (squares) shows a decreasing trend. Sample sizes for each group at each time point are listed below the x-axis.*

FDA Label Image

Finasteride Figure 4 (Finasteride Fig.4)

A line graph showing the percent of participants with an event plotted against years from randomization (0 to 5.5 years). Four lines represent different groups: Placebo (highest event rate), Finasteride, Doxazosin, and Combination (lowest event rate), illustrating event occurrence over time for each treatment group.*

FDA Label Image

Structutre (Finasteride Structure)

Chemical structure diagram of finasteride showing its characteristic steroid backbone with attached functional groups, including ketone and amide groups, as part of its molecular makeup.*

FDA Label Image

Remedy_label (Remedy Label)

Finasteride 5 mg film-coated tablets packaging label from RemedyRepack Inc. The label indicates a quantity of 30 tablets per box. It includes the NDC number 70518-3600-01, manufacturer information (Ascend Labs, LLC), and warnings to keep out of reach of children and not to be used or handled by women or children. Storage directions and repackager contact details are also present.*

FDA Label Image

Finasteride-fig.3_ (Fig 3finasteride)

A cumulative incidence line graph comparing Finasteride and Placebo groups over 48 months. The y-axis shows the percent of patients (0% to 15%), and the x-axis indicates observation time in months (0 to 48). Finasteride shows a lower event rate than Placebo. Below the graph, tables list cumulative events and number at risk per year for each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.